{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35069976", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "08"}, "DateRevised": {"Year": "2023", "Month": "01", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "12"}], "Language": ["eng"], "ELocationID": ["6168199", "10.1155/2022/6168199"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2022", "PubDate": {"Year": "2022"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "A New Perspective on the Treatment of Alzheimer's Disease and Sleep Deprivation-Related Consequences: Can Curcumin Help?", "Pagination": {"StartPage": "6168199", "MedlinePgn": "6168199"}, "Abstract": {"AbstractText": ["Sleep disturbances, as well as sleep-wake rhythm disorders, are characteristic symptoms of Alzheimer's disease (AD) that may head the other clinical signs of this neurodegenerative disease. Age-related structural and physiological changes in the brain lead to changes in sleep patterns. Conditions such as AD affect the cerebral cortex, basal forebrain, locus coeruleus, and the hypothalamus, thus changing the sleep-wake cycle. Sleep disorders likewise adversely affect the course of the disease. Since the sleep quality is important for the proper functioning of the memory, impaired sleep is associated with problems in the related areas of the brain that play a key role in learning and memory functions. In addition to synthetic drugs, utilization of medicinal plants has become popular in the treatment of neurological diseases. Curcuminoids, which are in a diarylheptanoid structure, are the main components of turmeric. Amongst them, curcumin has multiple applications in treatment regimens of various diseases such as cardiovascular diseases, obesity, cancer, inflammatory diseases, and aging. Besides, curcumin has been reported to be effective in different types of neurodegenerative diseases. Scientific studies exclusively showed that curcumin leads significant improvements in the pathological process of AD. Yet, its low solubility hence low bioavailability is the main therapeutic limitation of curcumin. Although previous studies have focused different types of advanced nanoformulations of curcumin, new approaches are needed to solve the solubility problem. This review summarizes the available scientific data, as reported by the most recent studies describing the utilization of curcumin in the treatment of AD and sleep deprivation-related consequences."], "CopyrightInformation": "Copyright \u00a9 2022 Esra K\u00fcpeli Akkol et al."}, "AuthorList": [{"Identifier": ["0000-0002-5829-7869"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Etiler, 06330 Ankara, Turkey."}], "LastName": "K\u00fcpeli Akkol", "ForeName": "Esra", "Initials": "E"}, {"Identifier": ["0000-0001-8799-6565"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Acibadem Mehmet Ali Ayd\u0131nlar University, 34752 Istanbul, Turkey."}], "LastName": "Bardakc\u0131", "ForeName": "Hilal", "Initials": "H"}, {"Identifier": ["0000-0002-0622-5150"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology, Faculty of Pharmacy, Erciyes University, 38039 Kayseri, Turkey."}], "LastName": "Y\u00fccel", "ForeName": "\u00c7i\u011fdem", "Initials": "\u00c7"}, {"Identifier": ["0000-0001-5829-6914"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Erciyes University, 38039 Kayseri, Turkey."}], "LastName": "\u015eeker Karatoprak", "ForeName": "G\u00f6k\u00e7e", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Ba\u015fkent University, Etimesgut, 06790 Ankara, Turkey."}], "LastName": "Karpuz", "ForeName": "B\u00fc\u015fra", "Initials": "B"}, {"Identifier": ["0000-0002-1736-4404"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan."}], "LastName": "Khan", "ForeName": "Haroon", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Curcumin"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Prospective Studies"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Sleep Deprivation"}], "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bhat A., Mahalakshmi A. M., Ray B., et al. Benefits of curcumin in brain disorders. BioFactors . 2019;45(5):666\u2013689. doi: 10.1002/biof.1533.", "ArticleIdList": ["10.1002/biof.1533", "31185140"]}, {"Citation": "Tang M., Taghibiglou C. The mechanisms of action of curcumin in Alzheimer\u2019s disease. Journal of Alzheimer's Disease . 2017;58(4):1003\u20131016. doi: 10.3233/JAD-170188.", "ArticleIdList": ["10.3233/JAD-170188", "28527218"]}, {"Citation": "Jagtap S., Meganathan K., Wagh V., Winkler J., Hescheler J., Sachinidis A. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-O-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Current Medicinal Chemistry . 2009;16(12):1451\u20131462. doi: 10.2174/092986709787909578.", "ArticleIdList": ["10.2174/092986709787909578", "19355899"]}, {"Citation": "Sharma R. A., Ireson C. R., Verschoyle R. D., et al. Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels. Clinical Cancer Research . 2001;7(5):1452\u20131458.", "ArticleIdList": ["11350917"]}, {"Citation": "El-Agamy D. S. Comparative effects of curcumin and resveratrol on aflatoxin B(1)-induced liver injury in rats. Archives of Toxicology . 2010;84(5):389\u2013396. doi: 10.1007/s00204-010-0511-2.", "ArticleIdList": ["10.1007/s00204-010-0511-2", "20112103"]}, {"Citation": "Aggarwal B. B. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annual Review of Nutrition . 2010;30(1):173\u2013199. doi: 10.1146/annurev.nutr.012809.104755.", "ArticleIdList": ["10.1146/annurev.nutr.012809.104755", "PMC3144156", "20420526"]}, {"Citation": "Alappat L., Awad A. Curcumin and obesity: evidence and mechanisms. Curcumin and obesity: evidence and mechanisms . 2010;68:729\u2013738.", "ArticleIdList": ["21091916"]}, {"Citation": "Darvesh A., Aggarwal B., Bishayee A. Curcumin and liver cancer: a review. Current Pharmaceutical Biotechnology . 2012;13(1):218\u2013228. doi: 10.2174/138920112798868791.", "ArticleIdList": ["10.2174/138920112798868791", "21466422"]}, {"Citation": "Funk J. L., Oyarzo J. N., Frye J. B., et al. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. Journal of Natural Products . 2006;69(3):351\u2013355. doi: 10.1021/np050327j.", "ArticleIdList": ["10.1021/np050327j", "PMC2533857", "16562833"]}, {"Citation": "Chandran B., Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytotherapy Research . 2012;26(11):1719\u20131725. doi: 10.1002/ptr.4639.", "ArticleIdList": ["10.1002/ptr.4639", "22407780"]}, {"Citation": "Lee K. S., Lee B. S., Semnani S., et al. Curcumin extends life span, improves health span, and modulates the expression of age-associated aging genes in Drosophila melanogaster. Rejuvenation Research . 2010;13(5):561\u2013570. doi: 10.1089/rej.2010.1031.", "ArticleIdList": ["10.1089/rej.2010.1031", "20645870"]}, {"Citation": "Liao V. H., Yu C. W., Chu Y. J., Li W. H., Hsieh Y. C., Wang T. T. Curcumin-mediated lifespan extension in Caenorhabditis elegans. Mechanisms of Ageing and Development . 2011;132(10):480\u2013487. doi: 10.1016/j.mad.2011.07.008.", "ArticleIdList": ["10.1016/j.mad.2011.07.008", "21855561"]}, {"Citation": "Salehi B., Calina D., Docea A. O., et al. Curcumin\u2019s nanomedicine formulations for therapeutic application in neurological diseases. Journal of Clinical Medicine . 2020;9(2):p. 430. doi: 10.3390/jcm9020430.", "ArticleIdList": ["10.3390/jcm9020430", "PMC7074182", "32033365"]}, {"Citation": "Noorafshan A., Karimi F., Kamali A. M., Karbalay-Doust S., Nami M. Could curcumin protect the dendritic trees of the CA1 neurons from shortening and shedding induced by chronic sleep restriction in rats? Life Sciences . 2018;198:65\u201370. doi: 10.1016/j.lfs.2018.02.021.", "ArticleIdList": ["10.1016/j.lfs.2018.02.021", "29455005"]}, {"Citation": "Kumar A., Singh A. Possible nitric oxide modulation in protective effect of (Curcuma longa , Zingiberaceae) against sleep deprivation-induced behavioral alterations and oxidative damage in mice. Phytomedicine . 2008;15(8):577\u2013586. doi: 10.1016/j.phymed.2008.02.003.", "ArticleIdList": ["10.1016/j.phymed.2008.02.003", "18586477"]}, {"Citation": "Noorafshan A., Karimi F., Karbalay-Doust S., Kamali A. M. Using curcumin to prevent structural and behavioral changes of medial prefrontal cortex induced by sleep deprivation in rats. EXCLI Journal . 2017;16:510\u2013520. doi: 10.17179/excli2017-139.", "ArticleIdList": ["10.17179/excli2017-139", "PMC5491911", "28694754"]}, {"Citation": "Noorafshan A., Karimi F., Kamali A. M., Karbalay-Doust S., Nami M. Restorative effects of curcumin on sleep-deprivation induced memory impairments and structural changes of the hippocampus in a rat model. Life Sciences . 2017;189:63\u201370. doi: 10.1016/j.lfs.2017.09.018.", "ArticleIdList": ["10.1016/j.lfs.2017.09.018", "28931469"]}, {"Citation": "Hita-Ya\u00f1ez E., Atienza M., Cantero J. L. Polysomnographic and subjective sleep markers of mild cognitive impairment. Sleep (Basel) . 2013;36(9):1327\u20131334. doi: 10.5665/sleep.2956.", "ArticleIdList": ["10.5665/sleep.2956", "PMC3738041", "23997365"]}, {"Citation": "Hu M., Zhang P., Li C., et al. Sleep disturbance in mild cognitive impairment: a systematic review of objective measures. Neurological Sciences . 2017;38(8):1363\u20131371. doi: 10.1007/s10072-017-2975-9.", "ArticleIdList": ["10.1007/s10072-017-2975-9", "28455768"]}, {"Citation": "Petersen R. C., Morris J. C. Mild cognitive impairment as a clinical entity and treatment target. Archives of Neurology . 2005;62(7):1160\u20133; discussion 1167. doi: 10.1001/archneur.62.7.1160.", "ArticleIdList": ["10.1001/archneur.62.7.1160", "16009779"]}, {"Citation": "Beaulieu-Bonneau S., Hudon C. Sleep disturbances in older adults with mild cognitive impairment. International Psychogeriatrics . 2009;21(4):654\u2013666. doi: 10.1017/S1041610209009120.", "ArticleIdList": ["10.1017/S1041610209009120", "19426575"]}, {"Citation": "Bombois S., Derambure P., Pasquier F., Monaca C. Sleep disorders in aging and dementia. The Journal of Nutrition, Health & Aging . 2010;14(3):212\u2013217. doi: 10.1007/s12603-010-0052-7.", "ArticleIdList": ["10.1007/s12603-010-0052-7", "20191256"]}, {"Citation": "Bidzan M., Bidzan L., Bidzan-Bluma I. Neuropsychiatric symptoms and faster progression of cognitive impairments as predictors of risk of conversion of mild cognitive impairment to dementia. Archives of Medical Science . 2017;13(5):1168\u20131177. doi: 10.5114/aoms.2017.68943.", "ArticleIdList": ["10.5114/aoms.2017.68943", "PMC5575224", "28883859"]}, {"Citation": "Muangpaisan W., Intalapaporn S., Assantachai P. Neuropsychiatric symptoms in the community-based patients with mild cognitive impairment and the influence of demographic factors. International Journal of Geriatric Psychiatry . 2008;23(7):699\u2013703. doi: 10.1002/gps.1963.", "ArticleIdList": ["10.1002/gps.1963", "18172914"]}, {"Citation": "Naismith S. L., Rogers N. L., Hickie I. B., Mackenzie J., Norrie L. M., Lewis S. J. G. Sleep well, think well: sleep-wake disturbance in mild cognitive impairment. Journal of Geriatric Psychiatry and Neurology . 2010;23(2):123\u2013130. doi: 10.1177/0891988710363710.", "ArticleIdList": ["10.1177/0891988710363710", "20354239"]}, {"Citation": "Kang D. W., Lee C. U., Lim H. K. Role of sleep disturbance in the trajectory of Alzheimer\u2019s disease. Clinical Psychopharmacology and Neuroscience . 2017;15(2):89\u201399. doi: 10.9758/cpn.2017.15.2.89.", "ArticleIdList": ["10.9758/cpn.2017.15.2.89", "PMC5426492", "28449556"]}, {"Citation": "Westerberg C. E., Lundgren E. M., Florczak S. M., et al. Sleep influences the severity of memory disruption in amnestic mild cognitive impairment: results from sleep self-assessment and continuous activity monitoring. Alzheimer Disease and Associated Disorders . 2010;24(4):325\u2013333. doi: 10.1097/WAD.0b013e3181e30846.", "ArticleIdList": ["10.1097/WAD.0b013e3181e30846", "PMC3025089", "20592579"]}, {"Citation": "Hita-Yanez E., Atienza M., Gil-Neciga E. L., Cantero J. Disturbed sleep patterns in elders with mild cognitive impairment: the role of memory decline and ApoE \u03b5 4 genotype. Current Alzheimer Research . 2012;9(3):290\u2013297. doi: 10.2174/156720512800107609.", "ArticleIdList": ["10.2174/156720512800107609", "22211488"]}, {"Citation": "Peter-Derex L., Yammine P., Bastuji H., Croisile B. Sleep and Alzheimer's disease. Sleep Medicine Reviews . 2015;19:29\u201338. doi: 10.1016/j.smrv.2014.03.007.", "ArticleIdList": ["10.1016/j.smrv.2014.03.007", "24846773"]}, {"Citation": "Vitiello M. V., Prinz P. N., Williams D. E., Frommlet M. S., Ries R. K. Sleep disturbances in patients with mild-stage Alzheimer\u2019s disease. Journal of Gerontology . 1990;45(4):M131\u2013M138. doi: 10.1093/geronj/45.4.M131.", "ArticleIdList": ["10.1093/geronj/45.4.M131", "2365965"]}, {"Citation": "Petit D., Gagnon J. F., Fantini M. L., Ferini-Strambi L., Montplaisir J. Sleep and quantitative EEG in neurodegenerative disorders. Journal of Psychosomatic Research . 2004;56(5):487\u2013496. doi: 10.1016/j.jpsychores.2004.02.001.", "ArticleIdList": ["10.1016/j.jpsychores.2004.02.001", "15172204"]}, {"Citation": "Bliwise D. L. Sleep in normal aging and dementia. Sleep . 1993;16(1):40\u201381. doi: 10.1093/sleep/16.1.40.", "ArticleIdList": ["10.1093/sleep/16.1.40", "8456235"]}, {"Citation": "Bliwise D. L. Sleep disorders in Alzheimer's disease and other dementias. Clinical Cornerstone . 2004;6(1):S16\u2013S28. doi: 10.1016/S1098-3597(04)90014-2.", "ArticleIdList": ["10.1016/S1098-3597(04)90014-2", "15259536"]}, {"Citation": "Walsh C. M., Blackwell T., Tranah G. J., et al. Weaker circadian activity rhythms are associated with poorer executive function in older women. Sleep (Basel) . 2014;37(12):2009\u20132016. doi: 10.5665/sleep.4260.", "ArticleIdList": ["10.5665/sleep.4260", "PMC4548515", "25337947"]}, {"Citation": "Foley D., Monjan A., Masaki K., et al. Daytime sleepiness is associated with 3-year incident dementia and cognitive decline in older Japanese-American men. Journal of the American Geriatrics Society . 2001;49(12):1628\u20131632. doi: 10.1111/j.1532-5415.2001.49271.x.", "ArticleIdList": ["10.1111/j.1532-5415.2001.49271.x", "11843995"]}, {"Citation": "Elwood P. C., Bayer A. J., Fish M., Pickering J., Mitchell C., Gallacher J. E. J. Sleep disturbance and daytime sleepiness predict vascular dementia. Journal of Epidemiology and Community Health . 2011;65(9):820\u2013824. doi: 10.1136/jech.2009.100503.", "ArticleIdList": ["10.1136/jech.2009.100503", "20675705"]}, {"Citation": "Virta J. J., Heikkil\u00e4 K., Perola M., et al. Midlife sleep characteristics associated with late life cognitive function. Sleep (Basel) . 2013;36(10):1533\u20131541. doi: 10.5665/sleep.3052.", "ArticleIdList": ["10.5665/sleep.3052", "PMC3773203", "24082313"]}, {"Citation": "Chen J. C., Espeland M. A., Brunner R. L., et al. Sleep duration, cognitive decline, and dementia risk in older women. Alzheimer's & Dementia . 2016;12(1):21\u201333. doi: 10.1016/j.jalz.2015.03.004.", "ArticleIdList": ["10.1016/j.jalz.2015.03.004", "PMC4679723", "26086180"]}, {"Citation": "Potvin O., Lorrain D., Forget H., et al. Sleep quality and 1-year incident cognitive impairment in community-dwelling older adults. Sleep (Basel) . 2012;35(4):491\u2013499. doi: 10.5665/sleep.1732.", "ArticleIdList": ["10.5665/sleep.1732", "PMC3296791", "22467987"]}, {"Citation": "Shi L., Chen S. J., Ma M. Y., et al. Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Medicine Reviews . 2018;40:4\u201316. doi: 10.1016/j.smrv.2017.06.010.", "ArticleIdList": ["10.1016/j.smrv.2017.06.010", "28890168"]}, {"Citation": "Cohen-Zion M., Stepnowsky C., Marler T., Shochat T., Kripke D. F., Ancoli-Israel S. Changes in cognitive function associated with sleep disordered breathing in older people. Journal of the American Geriatrics Society . 2001;49(12):1622\u20131627. doi: 10.1111/j.1532-5415.2001.49270.x.", "ArticleIdList": ["10.1111/j.1532-5415.2001.49270.x", "11843994"]}, {"Citation": "Benito-Le\u00f3n J., Bermejo-Pareja F., Vega S., Louis E. D. Total daily sleep duration and the risk of dementia: a prospective population-based study. European Journal of Neurology . 2009;16(9):990\u2013997. doi: 10.1111/j.1468-1331.2009.02618.x.", "ArticleIdList": ["10.1111/j.1468-1331.2009.02618.x", "19473367"]}, {"Citation": "Loerbroks A., Debling D., Amelang M., St\u00fcrmer T. Nocturnal sleep duration and cognitive impairment in a population-based study of older adults. International Journal of Geriatric Psychiatry . 2010;25(1):100\u2013109. doi: 10.1002/gps.2305.", "ArticleIdList": ["10.1002/gps.2305", "19548221"]}, {"Citation": "Tranah G. J., Blackwell T., Stone K. L., et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Annals of Neurology . 2011;70(5):722\u2013732. doi: 10.1002/ana.22468.", "ArticleIdList": ["10.1002/ana.22468", "PMC3244839", "22162057"]}, {"Citation": "for the Osteoporotic Fractures in Men (MrOS) Study Group, Blackwell T., Yaffe K., et al. Associations of objectively and subjectively measured sleep quality with subsequent cognitive decline in older community-dwelling men: the MrOS sleep study. Sleep (Basel) . 2014;37(4):655\u2013663. doi: 10.5665/sleep.3562.", "ArticleIdList": ["10.5665/sleep.3562", "PMC4044750", "24899757"]}, {"Citation": "Yaffe K., Laffan A. M., Harrison S. L., et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. Journal of the American Medical Association . 2011;306(6):613\u2013619. doi: 10.1001/jama.2011.1115.", "ArticleIdList": ["10.1001/jama.2011.1115", "PMC3600944", "21828324"]}, {"Citation": "Pase M. P., Himali J. J., Grima N. A., et al. Sleep architecture and the risk of incident dementia in the community. Neurology . 2017;89(12):1244\u20131250. doi: 10.1212/WNL.0000000000004373.", "ArticleIdList": ["10.1212/WNL.0000000000004373", "PMC5606917", "28835407"]}, {"Citation": "de Almondes K. M., Costa M. V., Malloy-Diniz L. F., Diniz B. S. Insomnia and risk of dementia in older adults: Systematic review and meta- analysis. Journal of Psychiatric Research . 2016;77:109\u2013115. doi: 10.1016/j.jpsychires.2016.02.021.", "ArticleIdList": ["10.1016/j.jpsychires.2016.02.021", "27017287"]}, {"Citation": "Bubu O. M., Brannick M., Mortimer J., et al. Sleep, cognitive impairment, and Alzheimer\u2019s disease: a systematic review and meta-analysis. Sleep (Basel) . 2017;40(1) doi: 10.1093/sleep/zsw032.", "ArticleIdList": ["10.1093/sleep/zsw032", "28364458"]}, {"Citation": "Jack CR Jr, Albert M. S., Knopman D. S., et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association Workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia: the journal of the Alzheimer's Association . 2011;7(3):257\u2013262. doi: 10.1016/j.jalz.2011.03.004.", "ArticleIdList": ["10.1016/j.jalz.2011.03.004", "PMC3096735", "21514247"]}, {"Citation": "Osorio R. S., Ayappa I., Mantua J., et al. The interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Neurobiology of Aging . 2014;35(6):1318\u20131324. doi: 10.1016/j.neurobiolaging.2013.12.030.", "ArticleIdList": ["10.1016/j.neurobiolaging.2013.12.030", "PMC4022140", "24439479"]}, {"Citation": "Ju Y. E., Lucey B. P., Holtzman D. M. Sleep and Alzheimer disease pathology--a bidirectional relationship. Nature reviews Neurology . 2014;10(2):115\u2013119. doi: 10.1038/nrneurol.2013.269.", "ArticleIdList": ["10.1038/nrneurol.2013.269", "PMC3979317", "24366271"]}, {"Citation": "Dang-Vu T. T., Schabus M., Desseilles M., Sterpenich V., Bonjean M., Maquet P. Functional neuroimaging insights into the physiology of human sleep. Sleep . 2010;33(12):1589\u20131603. doi: 10.1093/sleep/33.12.1589.", "ArticleIdList": ["10.1093/sleep/33.12.1589", "PMC2982729", "21120121"]}, {"Citation": "Kang J. E., Lim M. M., Bateman R. J., et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science . 2009;326(5955):1005\u20131007. doi: 10.1126/science.1180962.", "ArticleIdList": ["10.1126/science.1180962", "PMC2789838", "19779148"]}, {"Citation": "Huang Y. Effects of age and amyloid deposition on a\u03b2 dynamics in the human central nervous system. Archives of Neurology . 2012;69(1):51\u201358. doi: 10.1001/archneurol.2011.235.", "ArticleIdList": ["10.1001/archneurol.2011.235", "PMC3254706", "21911660"]}, {"Citation": "Rasmussen M. K., Mestre H., Nedergaard M. The glymphatic pathway in neurological disorders. Lancet Neurology . 2018;17(11):1016\u20131024. doi: 10.1016/S1474-4422(18)30318-1.", "ArticleIdList": ["10.1016/S1474-4422(18)30318-1", "PMC6261373", "30353860"]}, {"Citation": "Jessen N. A., Munk A. S., Lundgaard I., Nedergaard M. The glymphatic system: a beginner\u2019s guide. Neurochemical Research . 2015;40(12):2583\u20132599. doi: 10.1007/s11064-015-1581-6.", "ArticleIdList": ["10.1007/s11064-015-1581-6", "PMC4636982", "25947369"]}, {"Citation": "Xie L., Kang H., Xu Q., et al. Sleep drives metabolite clearance from the adult brain. Science . 2013;342(6156):373\u2013377. doi: 10.1126/science.1241224.", "ArticleIdList": ["10.1126/science.1241224", "PMC3880190", "24136970"]}, {"Citation": "Bero A. W., Yan P., Roh J. H., et al. Neuronal activity regulates the regional vulnerability to amyloid-\u03b2 deposition. Nature Neuroscience . 2011;14(6):750\u2013756. doi: 10.1038/nn.2801.", "ArticleIdList": ["10.1038/nn.2801", "PMC3102784", "21532579"]}, {"Citation": "Ju Y. E., McLeland J. S., Toedebusch C. D., et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurology . 2013;70(5):587\u2013593. doi: 10.1001/jamaneurol.2013.2334.", "ArticleIdList": ["10.1001/jamaneurol.2013.2334", "PMC3676720", "23479184"]}, {"Citation": "Musiek E. S., Holtzman D. M. Mechanisms linking circadian clocks, sleep, and neurodegeneration. Science . 2016;354(6315):1004\u20131008. doi: 10.1126/science.aah4968.", "ArticleIdList": ["10.1126/science.aah4968", "PMC5219881", "27885006"]}, {"Citation": "Zhou L., Gao Q., Nie M., et al. Degeneration and energy shortage in the suprachiasmatic nucleus underlies the circadian rhythm disturbance in ApoE\u2212/\u2212 mice: implications for Alzheimer's disease. Scientific Reports . 2016;6(1):p. 36335. doi: 10.1038/srep36335.", "ArticleIdList": ["10.1038/srep36335", "PMC5099891", "27824104"]}, {"Citation": "Kent B. A., Mistlberger R. E. Sleep and hippocampal neurogenesis: Implications for Alzheimer's disease. Frontiers in Neuroendocrinology . 2017;45:35\u201352. doi: 10.1016/j.yfrne.2017.02.004.", "ArticleIdList": ["10.1016/j.yfrne.2017.02.004", "28249715"]}, {"Citation": "Inouye S. K., Bogardus S. T., Jr., Charpentier P. A., et al. A multicomponent intervention to prevent delirium in hospitalized older patients. The New England Journal of Medicine . 1999;340(9):669\u2013676. doi: 10.1056/NEJM199903043400901.", "ArticleIdList": ["10.1056/NEJM199903043400901", "10053175"]}, {"Citation": "Meguro K., Yamaguchi S., Shimada M., Itoh M., Yamadori A. Striatal dopaminergic transmission and neocortical glucose utilization in Alzheimer's disease: a triple-tracer positron emission tomography study. Archives of Gerontology and Geriatrics . 2000;31(2):147\u2013158. doi: 10.1016/S0167-4943(00)00077-7.", "ArticleIdList": ["10.1016/S0167-4943(00)00077-7", "11090909"]}, {"Citation": "O'Keeffe S. T., Gavin K., Lavan J. N. Iron status and restless legs syndrome in the elderly. Age and Ageing . 1994;23(3):200\u2013203. doi: 10.1093/ageing/23.3.200.", "ArticleIdList": ["10.1093/ageing/23.3.200", "8085504"]}, {"Citation": "McCarten J. R., Kovera C., Maddox M. K., Cleary J. P. Triazolam in Alzheimer's disease: Pilot study on sleep and memory effects. Pharmacology, Biochemistry, and Behavior . 1995;52(2):447\u2013452. doi: 10.1016/0091-3057(95)00116-E.", "ArticleIdList": ["10.1016/0091-3057(95)00116-E", "8577814"]}, {"Citation": "Lloyd G. K., Lowenthal A., Javoy-Agid F., Constantidinis J. GAEAA receptor complex function in frontal cortex membranes from control and neurological patients. European Journal of Pharmacology . 1991;197(1-2):33\u201339. doi: 10.1016/0014-2999(91)90361-S.", "ArticleIdList": ["10.1016/0014-2999(91)90361-S", "1654259"]}, {"Citation": "Shaw S. H., Curson H., Coquelin J. E. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric inpatients. The Journal of International Medical Research . 1992;20(2):150\u2013161. doi: 10.1177/030006059202000207.", "ArticleIdList": ["10.1177/030006059202000207", "1521671"]}, {"Citation": "Shelton P. S., Hocking L. B. Zolpidem for Dementia-Related insomnia and nighttime wandering. The Annals of Pharmacotherapy . 1997;31(3):319\u2013322. doi: 10.1177/106002809703100309.", "ArticleIdList": ["10.1177/106002809703100309", "9066939"]}, {"Citation": "Daniele A., Albanese A., Gainotti G., Gregori B., Bartolomeo P. Zolpidem in Parkinson's disease. Lancet . 1997;349(9060):1222\u20131223. doi: 10.1016/S0140-6736(05)62416-6.", "ArticleIdList": ["10.1016/S0140-6736(05)62416-6", "9130951"]}, {"Citation": "Ansseau M., Pitchot W., Hansenne M., Moreno A. G. Psychotic reactions to zolpidem. Lancet . 1992;339(8796):p. 809. doi: 10.1016/0140-6736(92)91935-2.", "ArticleIdList": ["10.1016/0140-6736(92)91935-2", "1347827"]}, {"Citation": "Avorn J., Soumerai S. B., Everitt D. E., et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. The New England Journal of Medicine . 1992;327(3):168\u2013173. doi: 10.1056/NEJM199207163270306.", "ArticleIdList": ["10.1056/NEJM199207163270306", "1608408"]}, {"Citation": "Shorr R. I., Fought R. L., Ray W. A. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. Journal of the American Medical Association . 1994;271(5):358\u2013362. doi: 10.1001/jama.1994.03510290040034.", "ArticleIdList": ["10.1001/jama.1994.03510290040034", "8283585"]}, {"Citation": "Exum M. E., Phelps B. J., Nabers K. E., Osborne J. G. Sundown syndrome: Is it reflected in the use of PRN medications for nursing home residents? The Gerontologist . 1993;33(6):756\u2013761. doi: 10.1093/geront/33.6.756.", "ArticleIdList": ["10.1093/geront/33.6.756", "8314102"]}, {"Citation": "Tinetti M. E., Speechley M., Ginter S. E. Risk factors for falls among elderly persons living in the community. The New England Journal of Medicine . 1988;319(26):1701\u20131707. doi: 10.1056/NEJM198812293192604.", "ArticleIdList": ["10.1056/NEJM198812293192604", "3205267"]}, {"Citation": "Ray W. A., Griffin M. R., Schaffner W., Baugh D. K., Melton L. J., III Psychotropic drug use and the risk of hip fracture. The New England Journal of Medicine . 1987;316(7):363\u2013369. doi: 10.1056/NEJM198702123160702.", "ArticleIdList": ["10.1056/NEJM198702123160702", "2880292"]}, {"Citation": "Wang P. S., Bohn R. L., Glynn R. J., Mogun H., Avorn J. Zolpidem use and hip fractures in older people. Journal of the American Geriatrics Society . 2001;49(12):1685\u20131690. doi: 10.1111/j.1532-5415.2001.49280.x.", "ArticleIdList": ["10.1111/j.1532-5415.2001.49280.x", "11844004"]}, {"Citation": "King M. B., Tinetti M. E. Falls in community-dwelling older persons. Journal of the American Geriatrics Society . 1995;43(10):1146\u20131154. doi: 10.1111/j.1532-5415.1995.tb07017.x.", "ArticleIdList": ["10.1111/j.1532-5415.1995.tb07017.x", "7560708"]}, {"Citation": "Ray W. A., Thapa P. B., Gideon P. Benzodiazepines and the risk of falls in nursing home residents. Journal of the American Geriatrics Society . 2000;48(6):682\u2013685. doi: 10.1111/j.1532-5415.2000.tb04729.x.", "ArticleIdList": ["10.1111/j.1532-5415.2000.tb04729.x", "10855607"]}, {"Citation": "Brassington G. S., King A. C., Bliwise D. L. Sleep problems as a risk factor for falls in a sample of community- dwelling adults aged 64-99 years. Journal of the American Geriatrics Society . 2000;48(10):1234\u20131240. doi: 10.1111/j.1532-5415.2000.tb02596.x.", "ArticleIdList": ["10.1111/j.1532-5415.2000.tb02596.x", "11037010"]}, {"Citation": "Riemann D., Gann H., Dressing H., M\u00fcller W. E., Aldenhoff J. B. Influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep. Psychiatry Research . 1994;51(3):253\u2013267. doi: 10.1016/0165-1781(94)90013-2.", "ArticleIdList": ["10.1016/0165-1781(94)90013-2", "8208872"]}, {"Citation": "Schredl M., Weber B., Leins M. L., Heuser I. Donepezil-induced REM sleep augmentation enhances memory performance in elderly, healthy persons. Experimental Gerontology . 2001;36(2):353\u2013361. doi: 10.1016/S0531-5565(00)00206-0.", "ArticleIdList": ["10.1016/S0531-5565(00)00206-0", "11226748"]}, {"Citation": "Holsboer-Trachsler E., Hatzinger M., Stohler R., et al. Effects of the novel acetylcholinesterase inhibitor SDZ ENA 713 on sleep in man. Neuropsychopharmacology . 1993;8(1):87\u201392. doi: 10.1038/npp.1993.10.", "ArticleIdList": ["10.1038/npp.1993.10", "8424849"]}, {"Citation": "Yorston G. A., Gray R. Hypnopompic hallucinations with donepezil. Journal of Psychopharmacology . 2000;14(3):303\u2013304. doi: 10.1177/026988110001400315.", "ArticleIdList": ["10.1177/026988110001400315", "11106313"]}, {"Citation": "Ross J. S., Shua-Haim J. R. Aricept-induced nightmares in Alzheimer\u2019s disease: 2 case reports. Journal of the American Geriatrics Society . 1998;46(1):119\u2013120. doi: 10.1111/j.1532-5415.1998.tb01033.x.", "ArticleIdList": ["10.1111/j.1532-5415.1998.tb01033.x", "9434681"]}, {"Citation": "Rogers S. L., Doody R. S., Mohs R. C., Friedhoff L. T. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil study group. Archives of Internal Medicine . 1998;158(9):1021\u20131031. doi: 10.1001/archinte.158.9.1021.", "ArticleIdList": ["10.1001/archinte.158.9.1021", "9588436"]}, {"Citation": "Burns A., Rossor M., Hecker J., et al. The effects of donepezil in Alzheimer\u2019s disease -- results from a multinational trial. Dementia and Geriatric Cognitive Disorders . 1999;10(3):237\u2013244. doi: 10.1159/000017126.", "ArticleIdList": ["10.1159/000017126", "10325453"]}, {"Citation": "McKeith I., del Ser T., Spano E., et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double- blind, placebo-controlled international study. Lancet . 2000;356(9247):2031\u20132036. doi: 10.1016/S0140-6736(00)03399-7.", "ArticleIdList": ["10.1016/S0140-6736(00)03399-7", "11145488"]}, {"Citation": "Markowitz J. S., Gutterman E. M., Lilienfeld S., Papadopoulos G. Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine. Sleep . 2003;26(5):602\u2013606. doi: 10.1093/sleep/26.5.602.", "ArticleIdList": ["10.1093/sleep/26.5.602", "12938815"]}, {"Citation": "Stahl S. M., Markowitz J. S., Gutterman E. M., Papadopoulos G. Co-use of donepezil and hypnotics among Alzheimer\u2019s disease patients living in the community. Journal of Clinical Psychiatry . 2003;64(4):466\u2013472. doi: 10.4088/JCP.v64n0418.", "ArticleIdList": ["10.4088/JCP.v64n0418", "12716251"]}, {"Citation": "Maclean L. E., Collins C. C., Byrne E. J. Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep. International Psychogeriatrics . 2001;13(3):277\u2013288. doi: 10.1017/S1041610201007670.", "ArticleIdList": ["10.1017/S1041610201007670", "11768375"]}, {"Citation": "Reading P. J., Luce A. K., McKeith I. G. Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial. Movement Disorders . 2001;16(6):1171\u20131174. doi: 10.1002/mds.1204.", "ArticleIdList": ["10.1002/mds.1204", "11748755"]}, {"Citation": "Nelson K. M., Dahlin J. L., Bisson J., Graham J., Pauli G. F., Walters M. A. The essential medicinal chemistry of curcumin. Journal of Medicinal Chemistry . 2017;60(5):1620\u20131637. doi: 10.1021/acs.jmedchem.6b00975.", "ArticleIdList": ["10.1021/acs.jmedchem.6b00975", "PMC5346970", "28074653"]}, {"Citation": "Priyadarsini K. I. The chemistry of curcumin: from extraction to therapeutic agent. Molecules . 2014;19(12):20091\u201320112. doi: 10.3390/molecules191220091.", "ArticleIdList": ["10.3390/molecules191220091", "PMC6270789", "25470276"]}, {"Citation": "Lee W. H., Loo C. Y., Bebawy M., Luk F., Mason R., Rohanizadeh R. Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century. Current Neuropharmacology . 2013;11(4):338\u2013378. doi: 10.2174/1570159X11311040002.", "ArticleIdList": ["10.2174/1570159X11311040002", "PMC3744901", "24381528"]}, {"Citation": "Hatcher H., Planalp R., Cho J., Torti F. M., Torti S. V. Curcumin: from ancient medicine to current clinical trials. Cellular and Molecular Life Sciences . 2008;65(11):1631\u20131652. doi: 10.1007/s00018-008-7452-4.", "ArticleIdList": ["10.1007/s00018-008-7452-4", "PMC4686230", "18324353"]}, {"Citation": "Katsuyama Y., Kita T., Funa N., Horinouchi S. Curcuminoid biosynthesis by two type III polyketide synthases in the herb Curcuma longa. Biological Chemistry . 2009;284(17):11160\u201311170. doi: 10.1074/jbc.M900070200.", "ArticleIdList": ["10.1074/jbc.M900070200", "PMC2670121", "19258320"]}, {"Citation": "Wen M. M., el-Salamouni N. S., el-Refaie W. M., et al. Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges. Journal of Controlled Release . 2017;245:95\u2013107. doi: 10.1016/j.jconrel.2016.11.025.", "ArticleIdList": ["10.1016/j.jconrel.2016.11.025", "27889394"]}, {"Citation": "Nguyen T. T., Dung Nguyen T. T., Vo T. K., et al. Nanotechnology-based drug delivery for central nervous system disorders. Biomedicine & Pharmacotherapy . 2021;143:p. 112117. doi: 10.1016/j.biopha.2021.112117.", "ArticleIdList": ["10.1016/j.biopha.2021.112117", "34479020"]}, {"Citation": "Singh A. K., Rai S. N., Maurya A., et al. Therapeutic potential of phytoconstituents in management of Alzheimer\u2019s disease. Evidence-Based Complementary and Alternative Medicine, . 2021;2021, article 5578574:1\u201319. doi: 10.1155/2021/5578574.", "ArticleIdList": ["10.1155/2021/5578574", "PMC8208882", "34211570"]}, {"Citation": "Cheng K. K., Yeung C. F., Ho S. W., Chow S. F., Chow A. H. L., Baum L. Highly stabilized curcumin nanoparticles tested in an in vitro blood\u2013brain barrier model and in Alzheimer\u2019s disease Tg2576 mice. The AAPS Journal . 2013;15(2):324\u2013336. doi: 10.1208/s12248-012-9444-4.", "ArticleIdList": ["10.1208/s12248-012-9444-4", "PMC3675736", "23229335"]}, {"Citation": "Naksuriya O., Okonogi S., Schiffelers R. M., Hennink W. E. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials . 2014;35(10):3365\u20133383. doi: 10.1016/j.biomaterials.2013.12.090.", "ArticleIdList": ["10.1016/j.biomaterials.2013.12.090", "24439402"]}, {"Citation": "Yallapu M. M., Nagesh P. K. B., Jaggi M., Chauhan S. C. Therapeutic applications of curcumin nanoformulations. The AAPS Journal . 2015;17(6):1341\u20131356. doi: 10.1208/s12248-015-9811-z.", "ArticleIdList": ["10.1208/s12248-015-9811-z", "PMC4627456", "26335307"]}, {"Citation": "Ege D. Action mechanisms of curcumin in Alzheimer\u2019s disease and its brain targeted delivery. Materials . 2021;14(12):p. 3332. doi: 10.3390/ma14123332.", "ArticleIdList": ["10.3390/ma14123332", "PMC8234049", "34208692"]}, {"Citation": "Shabbir U., Rubab M., Tyagi A., Oh D. H. Curcumin and its derivatives as theranostic agents in Alzheimer\u2019s disease: the implication of nanotechnology. International Journal of Molecular Sciences . 2021;22(1):196\u2013223. doi: 10.3390/ijms22010196.", "ArticleIdList": ["10.3390/ijms22010196", "PMC7795367", "33375513"]}, {"Citation": "Tsai Y. M., Chien C. F., Lin L. C., Tsai T. H. Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration. International Journal of Pharmaceutics . 2011;416(1):331\u2013338. doi: 10.1016/j.ijpharm.2011.06.030.", "ArticleIdList": ["10.1016/j.ijpharm.2011.06.030", "21729743"]}, {"Citation": "Fonseca-Santos B., Gremi\u00e3o M. P., Chorilli M. Nanotechnology-based drug delivery systems for the treatment of Alzheimer\u2019s disease. International Journal of Nanomedicine . 2015;10:4981\u20135003. doi: 10.2147/IJN.S87148.", "ArticleIdList": ["10.2147/IJN.S87148", "PMC4531021", "26345528"]}, {"Citation": "Y\u00fccel \u00c7., \u015eeker Karatoprak G., De\u011fim \u0130. T. Anti-aging formulation of rosmarinic acid-loaded ethosomes and liposomes. Journal of Microencapsulation . 2019;36(2):180\u2013191. doi: 10.1080/02652048.2019.1617363.", "ArticleIdList": ["10.1080/02652048.2019.1617363", "31070486"]}, {"Citation": "Lazar A. N., Mourtas S., Youssef I., et al. Curcumin-conjugated nanoliposomes with high affinity for A\u03b2 deposits: Possible applications to Alzheimer disease. Nanomedicine: Nanotechnology, Biology and Medicine . 2013;9(5):712\u2013721. doi: 10.1016/j.nano.2012.11.004.", "ArticleIdList": ["10.1016/j.nano.2012.11.004", "23220328"]}, {"Citation": "Taylor M., Moore S., Mourtas S., et al. Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's A\u03b2 peptide. Nanomedicine: Nanotechnology, Biology and Medicine . 2011;7(5):541\u2013550. doi: 10.1016/j.nano.2011.06.015.", "ArticleIdList": ["10.1016/j.nano.2011.06.015", "21722618"]}, {"Citation": "Mourtas S., Lazar A. N., Markoutsa E., Duyckaerts C., Antimisiaris S. G. Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. European Journal of Medicinal Chemistry . 2014;80:175\u2013183. doi: 10.1016/j.ejmech.2014.04.050.", "ArticleIdList": ["10.1016/j.ejmech.2014.04.050", "24780594"]}, {"Citation": "Mourtas S., Canovi M., Zona C., et al. Curcumin-decorated nanoliposomes with very high affinity for amyloid-\u03b21-42 peptide. Biomaterials . 2011;32(6):1635\u20131645. doi: 10.1016/j.biomaterials.2010.10.027.", "ArticleIdList": ["10.1016/j.biomaterials.2010.10.027", "21131044"]}, {"Citation": "Kalani A., Chaturvedi P. Curcumin-primed and curcumin-loaded exosomes: potential neural therapy. Neural Regeneration Research . 2017;12(2):205\u2013206. doi: 10.4103/1673-5374.200799.", "ArticleIdList": ["10.4103/1673-5374.200799", "PMC5361498", "28400796"]}, {"Citation": "Wang H., Sui H., Zheng Y., et al. Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the tau protein through the AKT/GSK-3\u03b2 pathway. Nanoscale . 2019;11(15):7481\u20137496. doi: 10.1039/C9NR01255A.", "ArticleIdList": ["10.1039/C9NR01255A", "30942233"]}, {"Citation": "Blanco E., Shen H., Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature Biotechnology . 2015;33(9):941\u2013951. doi: 10.1038/nbt.3330.", "ArticleIdList": ["10.1038/nbt.3330", "PMC4978509", "26348965"]}, {"Citation": "Henrich-Noack P., Nikitovic D., Neagu M., et al. The blood-brain barrier and beyond: nano-based neuropharmacology and the role of extracellular matrix. Nanomedicine . 2019;17:359\u2013379. doi: 10.1016/j.nano.2019.01.016.", "ArticleIdList": ["10.1016/j.nano.2019.01.016", "30759369"]}, {"Citation": "Sancini G., Gregori M., Salvati E., Cambianica I., Re F. Functionalization with TAT-peptide enhances blood\u2013brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-\u03b2 peptide. Journal of Nanomedicine and Nanotechnology . 2013;4(3):1\u20138. doi: 10.4172/2157-7439.1000171.", "ArticleIdList": ["10.4172/2157-7439.1000171"]}, {"Citation": "Fernandes M., Lopes I., Magalh\u00e3es L., et al. Novel concept of exosome-like liposomes for the treatment of Alzheimer's disease. Journal of Controlled Release . 2021;336:130\u2013143. doi: 10.1016/j.jconrel.2021.06.018.", "ArticleIdList": ["10.1016/j.jconrel.2021.06.018", "34126168"]}, {"Citation": "Tiwari S. K., Agarwal S., Seth B., et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer\u2019s disease model via canonical wnt/\u03b2-catenin pathway. ACS Nano . 2014;8(1):76\u2013103. doi: 10.1021/nn405077y.", "ArticleIdList": ["10.1021/nn405077y", "24467380"]}, {"Citation": "Mathew A., Fukuda T., Nagaoka Y., et al. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s Disease. PLoS One . 2012;7(3, article e32616):1\u201310. doi: 10.1371/journal.pone.0032616.", "ArticleIdList": ["10.1371/journal.pone.0032616", "PMC3293842", "22403681"]}, {"Citation": "Cheng K. K., Chan P. S., Fan S., et al. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI) Biomaterials . 2015;44:155\u2013172. doi: 10.1016/j.biomaterials.2014.12.005.", "ArticleIdList": ["10.1016/j.biomaterials.2014.12.005", "25617135"]}, {"Citation": "Fan S., Zheng Y., Liu X., et al. Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer\u2019s disease. Drug Delivery . 2018;25(1):1091\u20131102. doi: 10.1080/10717544.2018.1461955.", "ArticleIdList": ["10.1080/10717544.2018.1461955", "PMC6116673", "30107760"]}, {"Citation": "Huang N., Lu S., Liu X. G., Zhu J., Wang Y. J., Liu R. T. PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering A\u03b2 generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer\u2019s disease mice. Oncotarget . 2017;8(46):81001\u201381013. doi: 10.18632/oncotarget.20944.", "ArticleIdList": ["10.18632/oncotarget.20944", "PMC5655257", "29113362"]}, {"Citation": "Meng F., Asghar S., Gao S., et al. A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease. Colloids and Surfaces, B: Biointerfaces . 2015;134:88\u201397. doi: 10.1016/j.colsurfb.2015.06.025.", "ArticleIdList": ["10.1016/j.colsurfb.2015.06.025", "26162977"]}, {"Citation": "Huo N., Zhang Y., Jin X., Li Y., Zhang L. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid \u03b2 aggregation in Alzheimer's disease. Journal of Photochemistry and Photobiology. B . 2019;190:98\u2013102. doi: 10.1016/j.jphotobiol.2018.11.008.", "ArticleIdList": ["10.1016/j.jphotobiol.2018.11.008", "30504054"]}, {"Citation": "Wu E. Curcumin-loaded lipid and polymer nanoparticles for Alzheimer\u2019s disease treatment. International Journal of Biomedical Sciences . 2021;17(3):34\u201339."}, {"Citation": "Gao C., Wang Y., Sun J., et al. Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice. Acta Biomaterialia . 2020;108:285\u2013299. doi: 10.1016/j.actbio.2020.03.029.", "ArticleIdList": ["10.1016/j.actbio.2020.03.029", "32251785"]}, {"Citation": "Kakkar V., Muppu S. K., Chopra K., Kaur I. P. Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. European Journal of Pharmaceutics and Biopharmaceutics . 2013;85(3):339\u2013345. doi: 10.1016/j.ejpb.2013.02.005.", "ArticleIdList": ["10.1016/j.ejpb.2013.02.005", "23454202"]}, {"Citation": "Tripathi S., Gupta U., Ujjwal R. R., Yadav A. K. Nano-Lipidic formulation and therapeutic strategies for Alzheimer\u2019s disease via intranasal route. Journal of Microencapsulation . 2021;38(7-8):572\u2013593. doi: 10.1080/02652048.2021.1986585.", "ArticleIdList": ["10.1080/02652048.2021.1986585", "34591731"]}, {"Citation": "Sintov A. C. Amylo Lipid nanovesicles: a self-assembled lipid-modified starch hybrid system constructed for direct nose-to-brain delivery of curcumin. International Journal of Pharmaceutics . 2020;588, article 119725", "ArticleIdList": ["32763387"]}, {"Citation": "Dhas N., Mehta T. Intranasal delivery of chitosan decorated PLGA core /shell nanoparticles containing flavonoid to reduce oxidative stress in the treatment of Alzheimer's disease. Journal of Drug Delivery Science and Technology . 2021;61, article 102242 doi: 10.1016/j.jddst.2020.102242.", "ArticleIdList": ["10.1016/j.jddst.2020.102242"]}, {"Citation": "Zhang L., Yang S., Wong L. R., Xie H., Ho P. C. L. In Vitro and In Vivo Comparison of Curcumin-Encapsulated Chitosan-Coated Poly(lactic-co-glycolic acid) Nanoparticles and Curcumin/Hydroxypropyl-\u03b2-Cyclodextrin Inclusion Complexes Administered Intranasally as Therapeutic Strategies for Alzheimer\u2019s Disease. Molecular Pharmaceutics . 2020;17(11):4256\u20134269. doi: 10.1021/acs.molpharmaceut.0c00675.", "ArticleIdList": ["10.1021/acs.molpharmaceut.0c00675", "33084343"]}, {"Citation": "Sood S., Jain K., Gowthamarajan K. Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment. Colloids and Surfaces, B: Biointerfaces . 2014;113:330\u2013337. doi: 10.1016/j.colsurfb.2013.09.030.", "ArticleIdList": ["10.1016/j.colsurfb.2013.09.030", "24121076"]}, {"Citation": "Mandal S. D., Mandal S., Patel J. Brain targeting efficiency of curcumin loaded mucoadhesive microemulsion through intranasal route. Journal of Pharmaceutical Investigation . 2016;46(2):179\u2013188. doi: 10.1007/s40005-016-0227-2.", "ArticleIdList": ["10.1007/s40005-016-0227-2"]}, {"Citation": "Sharma K. R. Nanorobot Drug delivery system for curcumin for enhanced bioavailability during treatment of Alzheimer\u2019s disease. Journal of Encapsulation and Adsorption Sciences . 2013;3(1):24\u201334. doi: 10.4236/jeas.2013.31004.", "ArticleIdList": ["10.4236/jeas.2013.31004"]}, {"Citation": "Giacomeli R., Izoton J. C., dos Santos R. B., Boeira S. P., Jesse C. R., Haas S. E. Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer's disease induced by \u03b2-amyloid 1-42 peptide in aged female mice. Brain Research . 2019;1721:146325\u2013146410. doi: 10.1016/j.brainres.2019.146325.", "ArticleIdList": ["10.1016/j.brainres.2019.146325", "31325424"]}, {"Citation": "Jagota A., Reddy M. Y. The effect of curcumin on ethanol induced changes in suprachiasmatic nucleus (SCN) and pineal. Cellular and Molecular Neurobiology . 2007;27(8):997\u20131006. doi: 10.1007/s10571-007-9203-8.", "ArticleIdList": ["10.1007/s10571-007-9203-8", "17846884"]}, {"Citation": "Li Y., Zhou M.-M., Gou X.-J., Zhao L., Shi X.-W., Jia W. Effects of curcumin on gut microbiota of interval sleep deprivation rats. Chinese Traditional and Herbal Drugs . 2016;47:794\u2013798."}, {"Citation": "Saliha C. K., Avadhany S. T. Hepatoprotective and antioxidant effect of curcumin on sleep deprived albino rats. Journal of Pharmacy & Bioallied Sciences . 2018;9(2):384\u2013390. doi: 10.22376/ijpbs.2018.9.2.b384-390.", "ArticleIdList": ["10.22376/ijpbs.2018.9.2.b384-390"]}, {"Citation": "Erfanizadeh M., Noorafshan A., Namavar M. R., Karbalay-Doust S., Talaei-Khozani T. Curcumin prevents neuronal loss and structural changes in the superior cervical (sympathetic) ganglion induced by chronic sleep deprivation, in the rat model. Biological Research . 2020;53(1):p. 31. doi: 10.1186/s40659-020-00300-8.", "ArticleIdList": ["10.1186/s40659-020-00300-8", "PMC7350621", "32650839"]}, {"Citation": "He Q., Chen X., Wu T., Li L., Fei X. Risk of dementia in long-term benzodiazepine users: evidence from a meta-analysis of observational studies. Journal of Clinical Neurology . 2019;15(1):9\u201319. doi: 10.3988/jcn.2019.15.1.9.", "ArticleIdList": ["10.3988/jcn.2019.15.1.9", "PMC6325366", "30375757"]}, {"Citation": "Srinivasan V., Kaur C., Pandi-Perumal S., Brown G. M., Cardinali D. P. Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value. International Journal of Alzheimer's Disease . 2010;2011, article 741974 doi: 10.4061/2011/741974.", "ArticleIdList": ["10.4061/2011/741974", "PMC3004402", "21197086"]}, {"Citation": "Pilipenko V., Narbute K., Pupure J., Rumaks J., Jansone B., Klusa V. Neuroprotective action of diazepam at very low and moderate doses in Alzheimer's disease model rats. Neuropharmacology . 2019;144:319\u2013326. doi: 10.1016/j.neuropharm.2018.11.003.", "ArticleIdList": ["10.1016/j.neuropharm.2018.11.003", "30408486"]}, {"Citation": "Schetinger M. R., Porto N. M., Moretto M. B., et al. New benzodiazepines alter acetylcholinesterase and ATPDase activities. Neurochemical Research . 2000;25(7):949\u2013955. doi: 10.1023/A:1007500424392.", "ArticleIdList": ["10.1023/A:1007500424392", "10959491"]}, {"Citation": "Frautschy S. A., Hu W., Kim P., et al. Phenolic anti-inflammatory antioxidant reversal of A\u03b2-induced cognitive deficits and neuropathology. Neurobiology of Aging . 2001;22(6):993\u20131005. doi: 10.1016/S0197-4580(01)00300-1.", "ArticleIdList": ["10.1016/S0197-4580(01)00300-1", "11755008"]}, {"Citation": "Baum L., Ng A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer\u2019s disease animal models. Journal of Alzheimer's disease . 2004;6(4):367\u2013377. doi: 10.3233/JAD-2004-6403.", "ArticleIdList": ["10.3233/JAD-2004-6403", "15345806"]}, {"Citation": "Yang F., Lim G. P., Begum A. N., et al. Curcumin Inhibits Formation of Amyloid \u03b2 Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo. The Journal of Biological Chemistry . 2005;280(7):5892\u20135901. doi: 10.1074/jbc.M404751200.", "ArticleIdList": ["10.1074/jbc.M404751200", "15590663"]}, {"Citation": "Balasubramanian K. Molecular orbital basis for yellow curry spice curcumin\u2019s prevention of Alzheimer\u2019s disease. Journal of Agricultural and Food Chemistry . 2006;54(10):3512\u20133520. doi: 10.1021/jf0603533.", "ArticleIdList": ["10.1021/jf0603533", "19127718"]}, {"Citation": "Garcia-Alloza M., Borrelli L. A., Rozkalne A., Hyman B. T., Bacskai B. J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. Journal of Neurochemistry . 2007;102(4):1095\u20131104. doi: 10.1111/j.1471-4159.2007.04613.x.", "ArticleIdList": ["10.1111/j.1471-4159.2007.04613.x", "17472706"]}, {"Citation": "Park S. Y., Kim H. S., Cho E. K., et al. Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food and Chemical Toxicology . 2008;46(8):2881\u20132887. doi: 10.1016/j.fct.2008.05.030.", "ArticleIdList": ["10.1016/j.fct.2008.05.030", "18573304"]}, {"Citation": "Ishrat T., Hoda N., Khan M. B., et al. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT) European Neuropsychopharmacology . 2009;19(9):636\u2013647. doi: 10.1016/j.euroneuro.2009.02.002.", "ArticleIdList": ["10.1016/j.euroneuro.2009.02.002", "19329286"]}, {"Citation": "Awasthi H., Tota S., Hanif K., Nath C., Shukla R. Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow. Life Sciences . 2010;86(3\u20134):87\u201394. doi: 10.1016/j.lfs.2009.11.007.", "ArticleIdList": ["10.1016/j.lfs.2009.11.007", "19925811"]}, {"Citation": "Wang Y., Yin H., Lou J., et al. Effects of curcumin on hippocampal Bax and Bcl-2 expression and cognitive function of a rat model of Alzheimer's disease. Neural Regeneration Research . 2011;6(24):1845\u20131849."}, {"Citation": "Dong S., Zeng Q., Mitchell E. S., et al. Curcumin enhances neurogenesis and cognition in aged rats: Implications for transcriptional interactions related to growth and synaptic plasticity. PLoS One . 2012;7(2, article e31211) doi: 10.1371/journal.pone.0031211.", "ArticleIdList": ["10.1371/journal.pone.0031211", "PMC3281036", "22359574"]}, {"Citation": "Sun C. Y., Qi S. S., Zhou P., et al. Neurobiological and pharmacological validity of curcumin in ameliorating memory performance of senescence-accelerated mice. Pharmacology, Biochemistry, and Behavior . 2013;105:76\u201382. doi: 10.1016/j.pbb.2013.02.002.", "ArticleIdList": ["10.1016/j.pbb.2013.02.002", "23402943"]}, {"Citation": "Banji O. J., Banji D., Ch K. Curcumin and hesperidin improve cognition by suppressing mitochondrial dysfunction and apoptosis induced by D-galactose in rat brain. Food and Chemical Toxicology . 2014;74:51\u201359. doi: 10.1016/j.fct.2014.08.020.", "ArticleIdList": ["10.1016/j.fct.2014.08.020", "25217884"]}, {"Citation": "Zhang L., Fang Y., Xu Y., et al. Curcumin improves amyloid \u03b2-peptide (1\u201342) induced spatial memory deficits through BDNF-ERK signaling pathway. PLoS One . 2015;10(6, article e0131525) doi: 10.1371/journal.pone.0131525.", "ArticleIdList": ["10.1371/journal.pone.0131525", "PMC4482657", "26114940"]}, {"Citation": "Yanagisawa D., Ibrahim N. F., Taguchi H., et al. Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice. Neurobiology of Aging . 2015;36(1):201\u2013210. doi: 10.1016/j.neurobiolaging.2014.07.041.", "ArticleIdList": ["10.1016/j.neurobiolaging.2014.07.041", "25179227"]}, {"Citation": "Doaa S., Ismail C., Nassra R., Zeitoun T., Nomair A. Downstream modulation of extrinsic apoptotic pathway in streptozotocin-induced Alzheimer\u2019s dementia in rats: erythropoietin versus curcumin. European Journal of Pharmacology . 2016;770:52\u201360.", "ArticleIdList": ["26638997"]}, {"Citation": "Vidal B., V\u00e1zquez-Roque R. A., Gnecco D., et al. Curcuma treatment prevents cognitive deficit and alteration of neuronal morphology in the limbic system of aging rats. Synapse . 2017;71(3, article e21952) doi: 10.1002/syn.21952.", "ArticleIdList": ["10.1002/syn.21952", "27997735"]}, {"Citation": "Moore T. L., Bowley B., Shultz P., et al. Chronic curcumin treatment improves spatial working memory but not recognition memory in middle-aged rhesus monkeys. Retrieved from. Gero Science . 2017;39(5\u20136):571\u2013584. doi: 10.1007/s11357-017-9998-2.", "ArticleIdList": ["10.1007/s11357-017-9998-2", "PMC5745216", "29047012"]}, {"Citation": "Singh S., Kumar P. Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats. Inflammopharmacology . 2017;25(1):69\u201379. doi: 10.1007/s10787-016-0297-9.", "ArticleIdList": ["10.1007/s10787-016-0297-9", "27853890"]}, {"Citation": "Sundaram J. R., Poore C. P., Sulaimee N. H. B., et al. Curcumin ameliorates neuroinflammation, neurodegeneration, and memory deficits in p 25 transgenic mouse model that bears hallmarks of Alzheimer\u2019s disease. Journal of Alzheimer's Disease . 2017;60(4):1429\u20131442. doi: 10.3233/JAD-170093.", "ArticleIdList": ["10.3233/JAD-170093", "PMC8092919", "29036814"]}, {"Citation": "Shi L. Y., Zhang L., Li H., et al. Protective effects of curcumin on acrolein-induced neurotoxicity in HT22 mouse hippocampal cells. Pharmacological Reports . 2018;70(5):1040\u20131046. doi: 10.1016/j.pharep.2018.05.006.", "ArticleIdList": ["10.1016/j.pharep.2018.05.006", "30144665"]}, {"Citation": "Teter B., Morihara T., Lim G. P., et al. Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis. Neurobiology of Disease . 2019;127:432\u2013448. doi: 10.1016/j.nbd.2019.02.015.", "ArticleIdList": ["10.1016/j.nbd.2019.02.015", "PMC8092921", "30951849"]}, {"Citation": "Lin L., Li C., Zhang D., Yuan M., Chen C. H., Li M. Synergic effects of berberine and curcumin on improving cognitive function in an Alzheimer\u2019s disease mouse model. Neurochemical Research . 2020;45(5):1130\u20131141. doi: 10.1007/s11064-020-02992-6.", "ArticleIdList": ["10.1007/s11064-020-02992-6", "32080784"]}, {"Citation": "Baum L., Lam C. W. K., Cheung S. K.-K., et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. Journal of Clinical Psychopharmacology . 2008;28(1):110\u2013113. doi: 10.1097/jcp.0b013e318160862c.", "ArticleIdList": ["10.1097/jcp.0b013e318160862c", "18204357"]}, {"Citation": "Ringman J. M., Frautschy S. A., Teng E., et al. Oral curcumin for Alzheimer\u2019s disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimer's Research & Therapy . 2012;4(5):p. 43. doi: 10.1186/alzrt146.", "ArticleIdList": ["10.1186/alzrt146", "PMC3580400", "23107780"]}, {"Citation": "Cox K. H., Pipingas A., Scholey A. B. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. Journal of Psychopharmacology . 2015;29(5):642\u2013651. doi: 10.1177/0269881114552744.", "ArticleIdList": ["10.1177/0269881114552744", "25277322"]}, {"Citation": "Rainey-Smith S. R., Brown B. M., Sohrabi H. R., et al. Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults. The British Journal of Nutrition . 2016;115(12):2106\u20132113. doi: 10.1017/S0007114516001203.", "ArticleIdList": ["10.1017/S0007114516001203", "27102361"]}, {"Citation": "Small G. W., Siddarth P., Li Z. P., et al. Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial. The American Journal of Geriatric Psychiatry . 2018;26(3):266\u2013277. doi: 10.1016/j.jagp.2017.10.010.", "ArticleIdList": ["10.1016/j.jagp.2017.10.010", "29246725"]}, {"Citation": "Gupta S. C., Patchva S., Aggarwal B. B. Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS Journal . 2013;15(1):195\u2013218. doi: 10.1208/s12248-012-9432-8.", "ArticleIdList": ["10.1208/s12248-012-9432-8", "PMC3535097", "23143785"]}, {"Citation": "Mancuso C., Barone E. Curcumin in clinical practice: myth or reality? Trends in Pharmacological Sciences . 2009;30(7):333\u2013334. doi: 10.1016/j.tips.2009.04.004.", "ArticleIdList": ["10.1016/j.tips.2009.04.004", "19523696"]}, {"Citation": "Goodpasture C. E., Arrighi F. E. Effects of food seasonings on the cell cycle and chromosome morphology of mammalian cells _in vitro_ with special reference to turmeric. Food and Cosmetics Toxicology . 1976;14(1):9\u201314. doi: 10.1016/S0015-6264(76)80356-2.", "ArticleIdList": ["10.1016/S0015-6264(76)80356-2", "943364"]}, {"Citation": "Urbina-Cano P., Bobadilla-Morales L., Ram\u00edrez-Herrera M. A., et al. DNA damage in mouse lymphocytes exposed to curcumin and copper. Journal of Applied Genetics . 2006;47(4):377\u2013382. doi: 10.1007/BF03194648.", "ArticleIdList": ["10.1007/BF03194648", "17132903"]}, {"Citation": "Sharma R. A., Euden S. A., Platton S. L., et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clinical Cancer Research . 2004;10(20):6847\u20136854. doi: 10.1158/1078-0432.CCR-04-0744.", "ArticleIdList": ["10.1158/1078-0432.CCR-04-0744", "15501961"]}, {"Citation": "Hanai H., Iida T., Takeuchi K., et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clinical Gastroenterology and Hepatology . 2006;4(12):1502\u20131506. doi: 10.1016/j.cgh.2006.08.008.", "ArticleIdList": ["10.1016/j.cgh.2006.08.008", "17101300"]}, {"Citation": "Lal B., Kapoor A., Agrawal P., Asthana O. P., Srimal R. C. Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytotherapy Research . 2000;14(6):443\u2013447. doi: 10.1002/1099-1573(200009)14:6<443::AID-PTR619>3.0.CO;2-V.", "ArticleIdList": ["10.1002/1099-1573(200009)14:6<443::AID-PTR619>3.0.CO;2-V", "10960899"]}, {"Citation": "Pinsornsak P., Niempoog S. The efficacy of Curcuma longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial. Journal of the Medical Association of Thailand . 2012;95:51\u201358.", "ArticleIdList": ["23964444"]}, {"Citation": "Ryan J. L., Heckler C. E., Ling M., et al. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiation Research . 2013;180(1):34\u201343. doi: 10.1667/RR3255.1.", "ArticleIdList": ["10.1667/RR3255.1", "PMC3998827", "23745991"]}, {"Citation": "Rahimnia A. R., Panahi Y., Alishiri G., Sharafi M., Sahebkar A. Impact of supplementation with curcuminoids on systemic inflammation in patients with knee osteoarthritis: findings from a randomized double-blind placebo-controlled trial. Drug research . 2015;65(10):521\u2013525. doi: 10.1055/s-0034-1384536.", "ArticleIdList": ["10.1055/s-0034-1384536", "25050518"]}, {"Citation": "Kuriakose M. A., Ramdas K., Dey B., et al. A randomized double-blind placebo-controlled phase iib trial of curcumin in Oral leukoplakia. Cancer Prevention Research . 2016;9(8):683\u2013691. doi: 10.1158/1940-6207.CAPR-15-0390.", "ArticleIdList": ["10.1158/1940-6207.CAPR-15-0390", "27267893"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "22"}, {"Year": "2021", "Month": "12", "Day": "3"}, {"Year": "2021", "Month": "12", "Day": "8"}, {"Year": "2022", "Month": "1", "Day": "24", "Hour": "8", "Minute": "50"}, {"Year": "2022", "Month": "1", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["35069976", "PMC8769857", "10.1155/2022/6168199"]}}], "PubmedBookArticle": []}